Choom™ (CSE: CHOO; OTCQB: CHOOF), an emerging fully-integrated cannabis company, is pleased to announce that today it is closing its acquisition of Specialty Medijuana Products Inc. pursuant to an amended and restated amalgamation agreement among Choom, Arbutus Brands Inc. and International Tungsten Inc. The Company announced the definitive agreement to effect the Transaction in a news release on March 19, 2018.
What is the common catalyst that caused certain weed companies to see up to 611% growth in months? Which company is next for this catalyst?
Aurora Cannabis Inc. (TSX: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) announced today that it intends to complete a $7 million investment in Choom Holdings Inc. (CSE:CHOO) (OTCQB: CHOOF), whereby Aurora will receive 9,859,155 common shares from Choom's treasury, priced at $0.71 per share, representing an 8% ownership interest.
Choom™ (CSE: CHOO; OTCQB: CHOOF) is pleased to announce a non-brokered private placement for gross proceeds of up to $10,000,000, including a $7,000,000 lead order from Aurora Cannabis Inc.
Aurora Cannabis Inc. (TSX: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) and Anandia Laboratories Inc. announced today that they have signed a binding term sheet whereby Aurora intends to acquire all of the issued and outstanding common shares of privately-held Anandia in an all share transaction valued at approximately $115 million on a fully diluted basis.
InMed Pharmaceuticals Inc. (TSX:IN) is pleased to announce that it has entered into an amended letter of engagement with Eight Capital, under which Eight Capital has now agreed to purchase, as underwriter, 14,444,560 units of the Company, on a “bought deal” basis pursuant to the filing of a shelf prospectus supplement, subject to all required regulatory approvals, at a price per Unit of $0.90, for total gross proceeds of $13,000,104.
WeedMD Inc. (TSX-V:WMD) (OTC:WDDMF) (FSE:4WE), a federally-licensed producer and distributor of medical cannabis, is pleased to announce that it has secured its Health Canada Cultivation Licence for the first four grow rooms within its 220,000 sq. ft. Phase I retrofit of its 610,000 sq. ft. modern greenhouse in Strathroy, Ontario.
Aurora Cannabis Inc. (TSX: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) today announced that it has signed a cannabis flower and trim supply agreement with Ascent Industries Corp's wholly-owned subsidiary, Agrima Botanicals Corp., a licensed producer of medical cannabis pursuant to Health Canada's Access to Cannabis for Medical Purposes Regulations.
MPX Bioceutical Corporation (CSE:MPX) (OTC:MPXEF) is pleased to announce that it has successfully completed the acquisition of 100% of the issued and outstanding shares of 8423695 Canada Inc. operating as Canveda, as previously announced on April 17, 2018. Canveda is a Licensed Producer under Health Canada’s Access to Cannabis for Medical Purposes Regulations having received its Cultivation License on June 12, 2017.
Equity.Guru looks at potential winners after the passing of Bill C-45 in the Canadian Senate. Their Conclusion: "We’ve had our eye on Choom for a while. We like the people, the space, the branding and the vertical integration into this new frontier."